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Abstract
The proper management of impaired glucose tolerance (IGT) in pregnant 
women is important for both obstetricians and diabetologists as this condition is of 
interest to both obstetrics and internal medicine. Although nutritional interven-
tion along with insulin treatment is the mainstream approach of IGT treatment 
in pregnant women, exercise intervention is another important component of 
the IGT management. A pedometer is a useful tool for objective exercise evalua-
tion. Nonetheless, its application in the management of IGT in pregnant women 
is limited. On the other hand, with the widespread use of smartphones equipped 
with pedometer function, exercise by walking is easily monitored and utilised in 
both healthy pregnant women and pregnant women with obesity and impaired 
glucose tolerance. In this chapter, we review the present perspective on the use of 
a pedometer in the management of IGT in pregnant women by introducing our 
recently published work.
Keywords: pregnancy, impaired glucose tolerance, gestational diabetes mellitus, 
exercise, pedometer
1. Introduction
Followed by recent substantial progress in the field of IT, smartphones equipped 
with a pedometer function have enabled us to measure the amount of steps we take 
daily and to estimate a daily caloric expenditure, which are useful tools of health 
self-monitoring. Pedometer or pedometer-equipped smartphones might theoreti-
cally help improving health of the people with conditions such as obesity, locomo-
tive problems, and impaired glucose tolerance. Nonetheless, there are a few reports 
demonstrating the effectiveness of a pedometer in weight control and metabolic 
control in non-pregnant individuals as well as in pregnant women partly because the 
difficulties in the setting of quantitative outcome of the study or the special nature 
of the subjects those who are reluctant to exercise. The management of impaired 
glucose tolerance requires strict blood glucose control through a proper manage-
ment of diet and exercise. However, the difficulty in quantification of the amount of 
exercise may let obstetricians and internists to prefer too strict nutritional control or 
easier use of insulin. We believe that exercise quantification, which is an important 
part of glycemic control, might be beneficial for the management of impaired glucose 
tolerance. In this chapter, we review a recent report on the role of a pedometer during 
effective management of impaired glucose tolerance during pregnancy.
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2. Maternal weight gain during pregnancy
Women gain approximately 12.5 kg of body weight during pregnancy [1]. This 
increase is due to the uterus and its contents, i.e., the foetus, the placenta, and the 
amniotic fluid, but also due to enlarged breasts with the extracellular fluid. This 
compartmentalisation makes the assessment of obesity and weight gain difficult 
during a short period of pregnancy, which lasts 9 months. Weight gain during 
pregnancy is associated with offspring obesity and cardiometabolic traits in early 
childhood in a trimester-specific fashion [2]. Greater rate of gestational weight gain 
in the first trimester of pregnancy was associated with increased risk of overweight 
and obesity from 2 years to 4 years of age, high waist circumference, high sum of 
skinfold thickness and higher diastolic blood pressure at 4 years of age. In contrast, 
Greater rate of gestational weight gain during the second and the third trimesters 
was associated with greater risk of large-for-gestational age neonates [2]. Our group 
has recently reported that in hyperemesis gravidarum, in which maternal undernu-
trition occurs in the first trimester of pregnancy, the pattern of foetal head growth 
differs from that of the normal pregnancy [3]. Moreover, the weight gain in slim and 
obese women should not be the same because of the differences in their nutritional 
demands during pregnancy. Association of gestational weight gain with adverse 
maternal and infant outcomes has been demonstrated by the LifeCycle Project-
Maternal Obesity and Childhood Outcomes Study Group [4]. From this large scale 
meta-analysis of 25 cohort studies, they concluded that maternal prepregnancy 
BMI, and to a lesser extent gestational weight gain, are associated with risks of 
adverse maternal and infant adverse outcomes. Gestational weight gain ranges that 
were associated with lower risks for adverse outcomes were 14.0 Kg to less than 16.0 
Kg for underweight women, 10.0 Kg to less than 18.0 Kg for normal weight women, 
2.0 Kg to less than 16.0 Kg for overweight women, and 2.0 Kg or less than 6.0 Kg 
for grade I obese women [4]. The Institute of Medicine and National Research 
Council revised its guidelines for weight gain during pregnancy according to the 
prepregnant nutritional status estimated by the pre-pregnancy BMI [5]. In Japan, 
according to the Healthy Parents and Children 21 by the Health, Labour and Welfare 
of Japan Government, the weight gain guidelines are 10–12 Kg for women with a 
pre-pregnancy BMI less than 18.5 Kg/m2, 7–12 Kg for women with a pre-pregnancy 
BMI of 18.5 to 25 Kg/m2, and appropriate increase for those with prepregnant BMI 
over 25 Kg/m2 [6]. However, adherence to the gestational weight gain recommenda-
tions seems to be limited for obese women in preventing increased birth weights 
[7]. In addition, behavioural interventions by the healthcare providers for the obese 
women are practically complicated due to several factors such as educational levels, 
ethnicity, and socio-economical levels. In particular, weight control is of huge 
importance during pregnancy complicated with diabetes and gestational diabetes, 
in which obesity is strongly associated with their pathophysiology.
3. Carbohydrate metabolism during pregnancy
The energy metabolism of women changes dramatically during pregnancy, as 
sufficient nutrition for the foetus must be provided. The foetus is nourished through 
the maternal-foetal interface called the placenta, by which essential nutrients, 
including the main foetal energy source—glucose and oxygen, are transported 
from the mother to the foetus. In line, foetal waste products such as carbon dioxide 
are transported from the foetus to the mother via the placenta. Various hormones 
are involved in the promotion of insulin resistance. Prolactin (PRL) and human 
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placental lactogen (hPL) have been reported to suppress glucose uptake through 
the action of GLUT4 [8, 9]. Moreover, a study of the effect of oestradiol (E2) and 
progesterone (P4) on the action of insulin has shown that P4 suppresses insulin 
signalling and reduces glucose uptake through a step-wise process by reducing the 
amount of protein in the insulin receptor to suppress the transport of GLUT4 to cell 
membranes, downregulating the PI3-kinase-independent pathway [8, 9]. It has also 
been shown that insulin sensitivity is reduced through the suppression of tyrosine 
phosphorylation in insulin receptors via increased E2 blood levels that have been 
observed in the latter half of human pregnancy [8, 9].
4. Impaired glucose tolerance during pregnancy
As mentioned in the previous section, pregnancy itself is to some extent 
diabetogenic in its third trimester. Thus, women who are obese or relatively 
older when becoming pregnant may have a higher risk of developing glucose 
intolerance during pregnancy. This condition is known as gestational diabetes. 
Alternatively, a woman may have pregestational diabetes or undiagnosed diabetes 
until she becomes pregnant. In all of these cases, the foetus is over-nourished, 
which results in obesity in new-born babies with higher perinatal morbidity and 
mortality and a higher risk of developing diabetes in the near future in cases of 
gestational diabetes [9]. As mentioned previously, a special metabolic change 
of pregnancy let a pregnant women change into insulin-resistant condition. For 
this reason, the maximum insulin demand in the third trimester of pregnancy of 
prepregnant diabetic women with type I and type 2 diabetes mellitus are reported 
to be 1.5 times and 2 times higher than those of pre-pregnant demands, respec-
tively [10]. The fundamental approach in the management of impaired glucose 
tolerance in pregnancy is to keep blood glucose levels as close to the non-pregnant 
levels as possible [11]. There are two important factors which need to be consid-
ered when achieving this goal, namely energy intake and energy expenditure. 
Measurements of blood glucose levels, glycosylated haemoglobin or albumin are 
routinely employed for the monitoring of diabetic control [12]. However, suitable 
energy expenditure, in other words, suitable exercise has not been studied in 
detail to date.
5. Exercise and carbohydrate metabolism during pregnancy
Regular exercise is recommended during pregnancy. In 2009, The American 
College of Obstetricians and Gynaecologists recommended that in the absence 
of contraindications such as pre-existing medical complications and pregnancy 
complications, pregnant women should be encouraged to engage in regular, 
moderate-intensity physical activity for 30 minutes or more daily [13]. Antenatal 
lifestyle interventions including exercise and diet for obese women also improved 
infant adiposity as well as maternal lifestyle behaviours at 6 months postpartum 
[14]. There are some evidence suggesting that pregnant women who engage in 
recreational physical activity have 50% lower risk of gestational diabetes and 40% 
risk reduction for preeclampsia [15].
Studies concerning the relationship between exercise and blood glucose levels 
have shown that, in healthy individuals, moderate amounts of exercise increase 
gluconeogenesis in the liver and other organs by decreasing insulin levels and 
elevating glucagon levels [8, 9]. Eighty percent of the glucose is used by skeletal 
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muscles, making them the major user of carbohydrates in the body [9]. There are 
two pathways for the use of carbohydrates in the skeletal muscles. One is a pathway 
by which the GLUT4 that is present in muscle cells is transported to the surface of 
cell membranes (translocation) and glucose uptake then occurs when insulin binds 
with receptors on the surface of the muscle cell membranes [9]. The other pathway 
is one by which insulin-independent glucose uptake is made possible by transloca-
tion of GLUT4 by adenosine monophosphate-dependent protein kinase that is 
activated in conjunction with muscle contractions [9]. Although the GLUT4 on 
the cell surface disappears 2 to 3 hours after exercise, the turn-over of the trans-
location of GLUT4 is upregulated by the exercise in response to the same levels of 
blood insulin concentrations [9]. Furthermore, the gene transcription of GLUT4 is 
enhanced after 10 or more hours after exercise [9]. As a result, even though glucose 
from the blood is uptaken by skeletal muscles, blood glucose levels are almost unal-
tered. However, although patients with type 2 DM are able to increase the uptake 
of glucose into skeletal muscle through exercise, they experience a decrease in the 
blood glucose level through the suppression of gluconeogenesis in the liver due to 
hyperinsulinemia [9]. Further, post-exercise promotion of glycogen synthesis and 
insulin sensitivity causes a drop in blood glucose levels. Recently, participation of 
angiotensin-(1–7), a vasoactive peptide of the renin-angiotensin system is demon-
strated in enhanced skeletal muscle insulin sensitivity after a bout of exercise [16]. 
It is known that patients treated with insulin and hypoglycaemic agents are particu-
larly susceptible to hypoglycaemia from the day of exercise to the following day [8]. 
Similar to type 2 DM, carbohydrate metabolism switches into insulin resistance in 
the latter half of pregnancy. Therefore, one may speculate that the blood glucose 
levels might be influenced by exercise during pregnancy. However, Artal et al. mea-
sured the blood glucose levels, insulin concentrations, and glucagon concentrations 
in women in the third trimester of normal pregnancies before and after a 15-minute 
treadmill exercise. The results indicated that the post-exercise blood glucose level and 
insulin level did not change, but that the glucagon level was elevated [17]. In contrast, 
Soultanakis et al. showed that continuous prolonged exercise in pregnancy with about 
55% VO2 or higher could result in hypoglycaemia after 45–60 minutes of continuous 
exercise, suggesting the importance of appropriate exercise plans in the management 
of blood glucose levels in women with impaired glucose tolerance [18]. In line, Artal 
suggested that one moderate bout of exercise of 30–45 minutes/day and one bout 
of exercise after each meal to burn at least 200 kcal or more per day is effective in 
obtaining or maintaining euglycemia during pregnancy [17]. It is noteworthy that 
a regular programme of exercise before pregnancy appears to lower the risk of 
developing gestational diabetes mellitus (GDM) [19].
6. Application of a pedometer as an exercise-monitoring tool
A rationale for the application of a pedometer for exercise quantification has 
been tested in non-pregnant women using doubly-labelled water, a gold stan-
dard measurement of free-living energy expenditure with that of the accelerom-
eter. The study demonstrated that the accelerometer is an alternative objective 
tool for the evaluation of exercise quantitatively in non-pregnant individuals 
[20]. Furthermore, Harrison et al. compared the accelerometer and pedometer 
as well as the subjective exercise assessment questionnaire, the International 
Physical Activity Questionnaire (IPAQ ), showing that the pedometer was supe-
rior to the accelerometer and IPAQ in an objective assessment of exercise during 
pregnancy [21].
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7. Application of a pedometer as a health care improving tool
7.1 Non-pregnant condition
The application of a pedometer for health improvement has been examined in 
the non-pregnancy context. Richardson et al. reported a meta-analysis of pedom-
eter-based walking interventions and weight loss [22]. They searched 6 electronic 
databases and found nine studies which met their inclusion criteria. Those studies 
demonstrated that pedometer-based walking programs resulted in a modest amount 
of weight loss, on average 0.05 kg per week during the interventions. Mitsui et al.  
showed gender differences in the relationship between steps/day and BMI in 
Japanese adults [23]. Walker et al. showed that a 10,000 steps per day for 6 months 
resulted in a 3.0 cm loss in waist circumference, whereas there were no differences 
in body mass index among 142 subjects, including both genders [24]. The applica-
tion of pedometer was examined for ovulation induction along with administration 
of clomiphene citrate in overweight women with polycystic ovary syndrome with 
greater number of spontaneous ovulation and pregnancy [25]. With respect to the 
effect of exercise monitored with a pedometer on carbohydrate metabolism, Huus 
et al. showed that physical activity assessed with a pedometer in healthy school-
children at the age of 8 and 12 longitudinally improved insulin sensitivity and 
decreased fasting C-peptide irrespective of the BMI [26]. This report is interesting 
because they investigated the association of exercise monitored with pedometer and 
insulin sensitivity qualitatively.
7.2 Pregnant condition
The clinical use of pedometers in obese pregnant women has been a controver-
sial topic. Streuling et al. performed a meta-analysis on clinical trials which dealt 
with the application of a pedometer in the management of gestational weight gain 
[27]. Out of 1380 studies, they identified 12 trials that met their inclusion criteria. 
In seven trials, gestational weight gain was lower in the exercise group than in the 
control group, whereas five trials showed a lower GWG in the control groups. In 
Asia, Jiang et al. reported that pregnant women being physically active assessed by 
pedometer had less weight gain during pregnancy [28]. In this report, the activity 
levels were divided into 4 groups as sedentary (< 5000 daily steps), low active 
(5000–7000 daily steps), somewhat active (7500–10,000 daily steps) and active 
(≥10,000 daily steps). In accordance with Jiang’s report, Cohen and Koski reported 
that both more than 5000 steps/day assessed by pedometer and daily energy intakes 
within 300 kcal of estimated energy requirements minimised postpartum weight 
retention of healthy pregnant women [29]. Although the application of a pedom-
eter for the control of gestational weight gain seems controversial based on the 
abovementioned meta-analysis, one of the most important questions is related to 
the use of a pedometer by obese women, because they may be reluctant to exercise 
and that could be one of the reasons why they are obese. Even in a recent multi-
institutional study conducted in Australia which used a randomised controlled 
trial in order to assess a pedometer-based intervention to increase activity and reduce 
excessive weight gain in pregnant women, the conclusion of the study showed nega-
tive results with the notion that the improvement of compliance with activity data 
recording and behavioural interventions delivered [30]. However, there are promising 
reports on the use of a pedometer for the management of overweight and obese 
pregnant women by active intervention with individualised nutritional support and 
individual exercise plans. For example, one study described an intervention at  
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16 to 20 weeks of gestation in overweight and obese women. The average number of 
steps after the intervention was over 10,000, along with the intake of 2000 kcal/day. 
This approach resulted in the prevention of excessive weight gain as well as exces-
sive postpartum weight retention [31]. The study clearly demonstrated that both 
nutritional and exercise interventions are necessary in order to achieve reasonable 
outcomes in the management of glucose metabolism in obese pregnant women. In 
comparison of a smartphone pedometer with a reference pedometer, The Yamax 
Digiwalker, Tokyo, Japan, a smartphone pedometer is even superior at a low 
walking speed, suggesting a smartphone pedometer might be superior to pregnant 
women who are not expected to walk faster. [32]. So, there is no problem in using a 
smartphone pedometer instead of stand-alone pedometer.
8.  Application of a pedometer for the management of impaired glucose 
tolerance in pregnant women
It is reasonable to assume that walking quantified by a pedometer is beneficial for 
the management of impaired glucose tolerance not only in non-pregnant subjects 
but also in pregnant subjects. Dahjio et al. reported a study on pedometer-monitored 
walking for the management of glucose in non-pregnant individuals. They examined 
a 12-week aerobic exercise training program monitored with a pedometer in type 
II diabetic Cameroonian women [33]. The subjects showed a significant reduction 
in body weight, waist circumference, and mean glycaemia after 12 weeks of the 
program. However, no study so far has reported the use of a pedometer in pregnant 
women with impaired glucose tolerance. Hence, we examined the feasibility of using 
a pedometer to quantify the exercise intensity and the relationship between the 
amount of exercise and carbohydrate metabolism in pregnant women with impaired 
Figure 1. 
Citizen digital pedometer TW700, connected to a laptop computer. The pedometer was connected to a laptop 
computer through a USB cable to upload steps.
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glucose tolerance employing a pedometer (Citizen Digital Pedometer TW 700 with 
high-sensitivity 3D acceleration sensor, CITIZEN SYSTEMS JAPAN CO., LTD, Japan) 
by which the recorded data of number of steps are stored chronologically for 30 
Figure 2. 




Relation between no. of steps and 
pre-prandial blood glucose level 
immediately following walking
No. of steps, morning & BL −0.12 n.s.
No. of steps, afternoon & BD 0.28 n.s.
No. of steps, night & vds 0.25 n.s.
Relation between no. of steps and 
postprandial blood glucose level 
immediately following walking
No. of steps, morning & AB 0.06 n.s.
No. of steps, afternoon & AL 0.02 n.s.
No. of steps, night & AD 0.03 n.s.
Relation between total no. of steps 
per day and blood glucose level
Total no. of steps per day & vds 0.06 n.s.
Total no. of steps per day & 
following day FBS
−0.02 n.s.
Relation between no. of steps per 
day and following day FBS
Insulin: yes 0.003 n.s.
Insulin: no −0.03 n.s.
Relation between no. of steps 
and change in blood glucose level 
before and after
No. of steps, morning & AB-BL −0.12 n.s.
No. of steps, afternoon & AL-BD −0.24 n.s.
No. of steps, night & AD-vds −0.05 n.s.
No. of steps, night & AD-following 
day FBS
−0.01 n.s.
Total no. of steps per day & 
following day FBS-FBS
−0.08 n.s.
FBS: Pre-breakfast blood glucose, AB: After-breakfast blood glucose, BL: Pre-lunch blood glucose, AL: After-lunch 
blood glucose, BD: Pre-dinner blood glucose, AD: After-dinner blood glucose, vds: Bedtime blood glucose, n.s.: not 
significant.
Table 1. 
Comparison of number of steps and blood glucose levels in 1-day based (from Ref. [34], with permission).
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consecutive days [34]. The data stored in the pedometer are transferred through USB 
port of the computer and analysed chronologically (Figures 1 and 2). In a 24-hour 
time frame, there was no correlation between the number of steps walked and 
pre- or postprandial blood glucose level immediately after walking, nor between 
the average number of steps per day and the fasting blood glucose level on the next 
day (Table 1). However, the 4-week data showed that there was a negative correla-
tion between the number of steps per day and the change in HbA1c levels (Table 2). 
Moreover, there was a negative correlation between the average number of steps per 
day and change in the maternal body weight (Table 2). A 1-week based data from 
the subjects administered with insulin indicated that there was a negative correlation 
between the average number of steps per day and the total amount of insulin admin-
istered per day. Our results indicated that pedometer-monitored walking improved 
insulin resistance without affecting blood glucose levels just after the bouts of walking. 
In addition, carrying the pedometer may have self-promoting effect for sustaining the 
exercise for the women with impaired glucose tolerance by noticing the improvement 
in the changes in the body weight and HbA1c levels in response to her steps walked. 
To conclude, our report was the first to show the usefulness of a pedometer for the 
management of IGT in pregnant women. We plan to continue studying this issue in 
future studies with higher numbers of participants along with nutritional counselling. 
Further studies are anticipated in order to design appropriate pedometer-monitored 
exercise plans not only for the management of IGT in pregnant women but also for 
that of the obese pregnant women. Nowadays, so many kinds of applications for preg-
nant women dealing with weight control, nutrition, foetal movement, maternal heart 
rates, it would be worthwhile to develop applications for incorporating pedometer data 
with body weight, maternal heart rate, ultrasound foetometric data and the param-




Relation of no. of steps per day and 
amount of change in HbA1c (comparison 
of 4-week based data)
Entire pregnancy −0.43 0.0263
Second trimester −0.64 0.0330
Third trimester 0.24 n.s.
Relation between avg. no. of steps and 
amount of change in GA (comparison of 
4-week based data)
Entire pregnancy −0.38 n.s. 
(0.082)
Second trimester −0.57 n.s. 
(0.109)
Third trimester 0.24 n.s.
Relation between no. of steps per day 
and amount of change in maternal body 
weight (comparison of 2-week based data)
Entire pregnancy −0.49 0.0005
First trimester −1(n = 2) n.s.
Second trimester −0.76 0.0003
Third trimester −0.11 n.s.
Relation between no. of steps per day and 
average amount of insulin administered 
per day (comparison of 1-week based 
data)
Entire pregnancy −0.43 <0.0001
First trimester 0.69 n.s.
Second trimester −0.42 0.0111
Third trimester −0.52 0.0005
No. of steps per day for entire period and infant birthweight (SD score) −0.22 n.s.
HbA1c: haemoglobin A1c, GA: Glycoalbumin, n.s.: not significant.
Table 2. 
Comparison of average number of steps per day and all data items (from Ref. [34], with permission).
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9. Conclusion
With the widespread use of smartphones equipped with pedometer function, 
walking exercises are easily monitored and utilised not only in normal but also 
in pregnant women with obesity and impaired glucose tolerance. Furthermore, 
data including footsteps, and pulse rates if smart watch will be used together with 
smartphone and information of the foetal growth, comprehensive management of 
the exercise and body weight control will be achieved. Further studies are expected 
to assess how many steps per day and how many bouts are optimal for the best 
blood sugar and body weight control during pregnancy.
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